10-60347124-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_020987.5(ANK3):​c.114+42301A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.697 in 148,868 control chromosomes in the GnomAD database, including 37,470 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.70 ( 37470 hom., cov: 24)

Consequence

ANK3
NM_020987.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.197

Publications

5 publications found
Variant links:
Genes affected
ANK3 (HGNC:494): (ankyrin 3) Ankyrins are a family of proteins that are believed to link the integral membrane proteins to the underlying spectrin-actin cytoskeleton and play key roles in activities such as cell motility, activation, proliferation, contact, and the maintenance of specialized membrane domains. Multiple isoforms of ankyrin with different affinities for various target proteins are expressed in a tissue-specific, developmentally regulated manner. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. Ankyrin 3 is an immunologically distinct gene product from ankyrins 1 and 2, and was originally found at the axonal initial segment and nodes of Ranvier of neurons in the central and peripheral nervous systems. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Feb 2011]
ANK3 Gene-Disease associations (from GenCC):
  • intellectual disability-hypotonia-spasticity-sleep disorder syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • intellectual disability
    Inheritance: AR, AD Classification: MODERATE, LIMITED Submitted by: ClinGen, Ambry Genetics
  • Tourette syndrome
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.892 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ANK3NM_020987.5 linkc.114+42301A>G intron_variant Intron 1 of 43 ENST00000280772.7 NP_066267.2 Q12955-3
ANK3NM_001204404.2 linkc.64-67485A>G intron_variant Intron 1 of 43 NP_001191333.1 Q12955-4
ANK3NM_001320874.2 linkc.114+42301A>G intron_variant Intron 1 of 42 NP_001307803.1
ANK3NM_001204403.2 linkc.97-67485A>G intron_variant Intron 2 of 43 NP_001191332.1 Q12955-5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ANK3ENST00000280772.7 linkc.114+42301A>G intron_variant Intron 1 of 43 1 NM_020987.5 ENSP00000280772.1 Q12955-3

Frequencies

GnomAD3 genomes
AF:
0.697
AC:
103687
AN:
148750
Hom.:
37446
Cov.:
24
show subpopulations
Gnomad AFR
AF:
0.495
Gnomad AMI
AF:
0.756
Gnomad AMR
AF:
0.730
Gnomad ASJ
AF:
0.791
Gnomad EAS
AF:
0.749
Gnomad SAS
AF:
0.915
Gnomad FIN
AF:
0.746
Gnomad MID
AF:
0.806
Gnomad NFE
AF:
0.777
Gnomad OTH
AF:
0.725
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.697
AC:
103755
AN:
148868
Hom.:
37470
Cov.:
24
AF XY:
0.704
AC XY:
50898
AN XY:
72342
show subpopulations
African (AFR)
AF:
0.496
AC:
19975
AN:
40304
American (AMR)
AF:
0.730
AC:
10856
AN:
14864
Ashkenazi Jewish (ASJ)
AF:
0.791
AC:
2727
AN:
3448
East Asian (EAS)
AF:
0.748
AC:
3765
AN:
5034
South Asian (SAS)
AF:
0.915
AC:
4219
AN:
4612
European-Finnish (FIN)
AF:
0.746
AC:
7418
AN:
9948
Middle Eastern (MID)
AF:
0.799
AC:
230
AN:
288
European-Non Finnish (NFE)
AF:
0.777
AC:
52383
AN:
67400
Other (OTH)
AF:
0.726
AC:
1496
AN:
2062
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
1339
2677
4016
5354
6693
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
804
1608
2412
3216
4020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.712
Hom.:
9898
Bravo
AF:
0.682
Asia WGS
AF:
0.797
AC:
2769
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
3.1
DANN
Benign
0.87
PhyloP100
-0.20
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7084499; hg19: chr10-62106882; API